TLN-121 — Interim data
2027
In 2027, we plan to announce interim data and provide long-term development guidance about what we believe could be a practice changing medicine in lymphoma.Source filing
STANDARD BIOTOOLS INC · Data as of 2026-09-08
2027
In 2027, we plan to announce interim data and provide long-term development guidance about what we believe could be a practice changing medicine in lymphoma.Source filing
2027
We ultimately expect to answer such questions with interim clinical response and safety data in 2027.Source filing